Regulation of the peroxisomal β-oxidation-dependent pathway by peroxisome proliferator-activated receptor α and kinases

Biochemical Pharmacology

Volumn 60, Issue 8, 2000, Pages 1027-1032

  Latruffe, Norbert ^a   Malki, Mustapha Cherkaoui ^a   Nicolas Frances, Valérie ^a   Clemencet, Marie Claude ^a   Jannin, Brigitte ^a   Berlot, Jean Pierre ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Fatty acids; Peroxisome; Phosphorylation; PI3 kinase; PKC; PPAR

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; FIBRIC ACID DERIVATIVE; HERBICIDE; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHOTRANSFERASE; PLASTICIZER; PROTEIN KINASE C;

ANIMAL CELL; FATTY ACID OXIDATION; GENE TARGETING; GENETIC TRANSCRIPTION; LIPID METABOLISM; LIPOGENESIS; NONHUMAN; ORGAN DISTRIBUTION; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0034668147     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00416-0     Document Type: Article

References (43)

1. Rhodin J, Correlation of Ultrastructural Organization and Function in Normal and Experimentally Changed Convoluted Tubule Cells of the Mouse Kidney, PhD thesis. Stockholm, Aktiebolaget Godvil, 1954.
2. Baudhuin P., Beaufay H., de Duve C. Combined biochemical and morphological study of particulate fractions from rat liver. Analysis of preparations enriched in lysosomes or in particles containing urate oxidase, D-amino acid oxidase, and catalase. J Cell Biol. 26:1965;219-243.
3. Biochimie (1993) Special issue on "Peroxisomes: biochemistry, molecular biology and genetic diseases" 75 (3/4) 141-316 (N. Latruffe ed.) Elsevier, Paris.
4. Piot C., Veerkamp J.F., Bauchart D., Hocquette J.F. Contribution of mitochondria and peroxisomes to palmitate oxidation in rat and bovine tissues. Comp Biochem Physiol B Biochem Mol Biol. 121:1998;185-194.
5. Hess R., Staubli W., Riess W. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature. 208:1965;856-858.
6. Cohen A.J., Grasso P. Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man. Food Cosmet Toxicol. 19:1981;585-605.
7. Latruffe N., Vamecq J. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism. Biochimie. 79:1997;81-94.
8. Deschatrette J., Weiss M.C. Characterization of differentiated and dedifferentiated clones from a rat hepatoma. Biochimie. 56:1974;1603-1611.
9. Passilly P., Schohn H., Jannin B., Cherkaoui Malki M., Boscoboinik D., Dauça M., Latruffe N. Phosphorylation of peroxisome proliferator-activated receptor α in rat Fao cells and stimulation by ciprofibrate. Biochem Pharmacol. 58:1999;1001-1008.
10. Miyazawa S., Hayashi H., Hijikata M., Ishii N., Furuta H., Kagamiyata T., Osumi T., Hashimoto T. Complete nucleotide sequence of cDNA and predicted amino acid sequence of rat acyl-CoA oxidase. J Biol Chem. 262:1987;8131-8137.
11. Caira F., Clemencet M.C., Cherkaoui Malki M., Dieuaide-Noubhani M., Pacot C., Van Veldhoven P.P., Latruffe N. Differential regulation by a peroxisome proliferator of the different multifunctional proteins (MFPs) in guinea pig cDNA cloning of the guinea pig D-specific multifunctional protein . Biochem J. 330:1998;1361-1368.
12. Nicolas-Frances V., Dasari V.K., Abruzzi E., Osumi T., Latruffe N. The peroxisome proliferator response element (PPRE) present at position -661/-669 in the rat liver 3-ketoacyl-CoA thiolase B gene functionally interacts differently with PPARα and HNF-4. Biochem Biophys Res Commun. 269:2000;347-351.
13. Passillly-Degrace P, Jannin B, Boscoboinik D, Motojima K and Latruffe N, Ciprofibrate stimulates protein kinase C-dependent phosphorylations of an 85 kDa in rat Fao hepatic derived cells. Biochimie, in press, 2000.
14. Reif K., Gout I., Waterfield M.D., Cantrell D.A. Divergent regulation of phosphatidylinositol 3-kinase p85α and p85β isoforms upon T cell activation. J Biol Chem. 268:1993;10780-10788.
15. Issemann I., Green S. Activation of a member of the steroid receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
16. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 68:1992;879-887.
17. Braissant O., Foufelle F., Scotto C., Dauça M., Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs) Tissue distribution of PPAR-α, -β, and -γ in the adult rat . Endocrinology. 137:1996;354-366.
18. Lemberger T., Desvergne B., Wahli W. Peroxisome proliferator-activated receptor A nuclear receptor signaling pathway in lipid physiology . Ann Rev Cell Dev Biol. 12:1996;335-363.
19. Vamecq J., Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet. 354:1999;141-148.
20. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M.G., Wahli W. Fatty acids, eicosanoids, and hypolipidaemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol. 11:1997;779-791.
21. Osada S., Tsukamoto T., Takiguchi M., Mori M., Osumi T. Identification of an extended half-site motif required for the function of peroxisome proliferator-activated receptor α Genes Cells. 2:1997;315-327.
22. Bardot O., Aldridge T.C., Latruffe N., Green S. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem Biophys Res Commun. 192:1993;37-45.
23. Jackson S.P. Regulating transcription factor activity by phosphorylation. Trends Cell Biol. 2:1992;104-108.
24. Shalev A., Siegrist-Kaiser C.A., Yen P.M., Whali W., Burger A.G., Chin W.W., Meier C.A. The peroxisome proliferator-activated receptor α is a phosphoprotein Regulation by insulin . Endocrinology. 137:1996;4499-4502.
25. Zhou Y.C., Waxman D.J. Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPAR alpha) signaling pathways. Growth hormone inhibition of PPAR alpha transcriptional activity mediated by STAT 5b. J Biol Chem. 274:1999;2672-2682.
26. Juge-Aubry C.E., Hammar E., Siegrist-Kaizer C., Pernin A., Takeshita A., Chin W.W., Burger A.G., Meier C.A. Relation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of the ligand-independent trans-activating domain. J Biol Chem. 274:1999;10505-10510.
27. Zhang B., Berger J., Zhou G., Elbrecht A., Biswas S., White-Carrington S., Szalkowski D., Moller D.E. Insulin and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. J Biol Chem. 271:1996;31771-31774.
28. Hu E., Kim J.B., Sarraf P., Spiegelman B.M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ Science. 274:1996;2100-2103.
29. Adams M., Reginato M.J., Shao D.L., Lazar M.A., Chatterjee V.K. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem. 272:1997;5128-5131.
30. Camp H.S., Tafuri S.R. Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase. J Biol Chem. 272:1997;10811-10816.
31. Reginato M.J., Krakow S.L., Bailey S.T., Lazar M.A. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma. J Biol Chem. 273:1998;1855-1858.
32. Ristow M., Muller-Wieland D., Pfeiffer A., Krone W., Kahn C.R. Obesity associated with a mutation in a genetic regulator of adipocyte diffentiation. N Engl J Med. 339:1998;953-959.
33. Shao D., Rangwala S.M., Bailey S.T., Krakow S.L., Reginato M.J., Lazar M.A. Interdomain communication regulating ligand binding by PPAR-gamma. Nature. 396:1998;377-380.
34. Camp H.S., Tafuri S.R., Leff T. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma 1 and negatively regulates its transcriptional activity. Endocrinology. 140:1999;392-397.
35. Brodie A.E., Manning V.A., Hu C.Y. Inhibitors of preadipocyte differentiation induce COUP-TF binding to a PPAR/RXR binding sequence. Biochem Biophys Res Commun. 228:1996;655-661.
36. Rokos C.L., Ledwith B.J. Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells. J Biol Chem. 272:1997;13452-13457.
37. Orellana A., Holuigue L., Hidalgo P.C., Faundez V., Gonzalez A., Bronfman M. Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated rat hepatocytes. Eur J Biochem. 215:1993;903-906.
38. Orellana A., Hidalgo P.C., Morales M.N., Mezzano D., Bronfman M. Palmitoyl-CoA and the acyl-CoA thioester of the carcinogenic peroxisome-proliferator ciprofibrate potentiate diacylglycerol-activated protein kinase C by decreasing the phosphatidylserine requirement of the enzyme. Eur J Biochem. 190:1990;57-62.
39. Passilly P., Jannin B., Latruffe N. Influence of peroxisome proliferators on phosphoprotein levels in human and rat hepatic-derived cell lines. Eur J Biochem. 230:1995;316-321.
40. Blackshear P.J., Haupt D.M., Stumpo D.J. Insulin activation of protein kinase C A reassessment . J Biol Chem. 266:1991;10946-10952.
41. Hayashi T., Okamoto M., Yoshimasa Y., Inoue G., Yamada K., Sono S., Shigemoto M., Suga J., Kuzuya H., Nakao K. Insulin-induced activation of phosphatidylinositol 3-kinase in Fao cells. Diabetologica. 39:1996;515-522.
42. Sanchez-Margalet V. Stimulation of glycogen synthesis by insulin requires S6 kinase and phosphatidylinositol-3-kinase in HTC-IR cells. J Cell Physiol. 182:2000;182-188.
43. Motojima K., Passilly P., Jannin B., Latruffe N. Protein phosphorylation by peroxisome proliferators Species-specific stimulation of protein kinases and its role in PP-induced transcriptional activation . Ann NY Acad Sci. 804:1996;413-423.